Website address: www.oxymap.com
We manufacture the Oxymap T1 retinal oximeter which measures oxygen saturation as well as vessel diameter. It allows metabolic imaging of the retina for investigation of the pathophysiology of common eye diseases. It received CE Declaration of conformity in 2013. It is being used in close to 30 research centers and university hospitals worldwide.
It is based on top of a Topcon fundus camera.
Website address: www.orayainc.com
Company contacts: Jackie Ferreira
Sr. Director Communications
Oraya Therapeutics, Inc.
8000 Jarvis Aavenue, Suite 200
Newark, CA. 94560
The Oraya Therapy(tm) Stereotactic Radiotherapy for wet AMD has been shown to reduce the number of anti-VEGF injections while maintaining vision. This therapy is being used in the United Kingdom, Switzerland and Germany with eleven locations offering treatment in these three countries. Patient results and case studies are available at booth M100 and will be presented Saturday Sept. 19 from 10-11 am. Room: Clio.
Website address: www.optovue.com
Optovue, Inc. pushes the frontiers of ocular imaging with uncompromising clinical integrity to improve the lives of patients around the world. Optovue has led the industry in Spectral-Domain OCT innovation with XR Avanti and iVue, and continues the innovation push with the new iFusion – integrating the iCam fundus camera and iVue OCT into one system for superior practice efficiency, affordability and flexibility.
Website address: www.optos.com
Company contacts: Optos plc
Scotland KY11 8GR
Tel: +44 (0)1383 843300
Optos' patented ultra-widefield digital scanning laser technology acquires images that support the detection, diagnosis, analysis, documentation and management of ocular pathology and systemic disease that may first present in the periphery. These conditions may otherwise go undetected using traditional examination techniques and equipment. Simultaneous, non-contact, central pole-to-periphery views of up to 82% or 200 degrees of the retina are displayed in one single capture, compared to 45 degrees achieved with conventional methods. Optos offers desktop devices offering multiple wavelength imaging,including options for color, red-free, autofluorescence and angiography together with feature-rich image viewing software to view the images from Optos devices.
Website address: www.okuvision.de
Company contacts: Okuvision GmbH
E-Mail: firstname.lastname@example.org Phone: +49 7121 36403-299
Okuvision offers the "OkuStim®" system, which is one of the first outpatient treatments for retinitis pigmentosa (RP) proven in clinical studies. The Okuvision therapy can verifiably slow down the progression of the disease and thereby preserve vision for longer by guiding weak electrical pulses to the retina. OkuStim® is a CE approved medical product and can only be used with a medical prescription. The system is set by the doctor to meet the individual characteristics of each patient. Patients can treat themselves at home or at eye-centers with regular eye check-ups at hospitals.
Website address: www.oertli-instruments.com
Company contacts: email@example.com
Phone: +41 71 747 42 0
For exactly 60 years we have been successfully developing, producing and selling surgical equipment for cataract, glaucoma and vitreoretinal procedures that enables doctors and OR personnel to work in a safer, easier and more efficient way.
For the first time we will feature our new OS4 all-in-one surgical platform to the audience of the Euretina congress. This Swiss innovation full-fills all needs of a retina surgeon and beyond.
OS4 – The Essence of Perfection.
Website address: www.od-os.com
Company contacts: OD-OS GmbH
Tel.: +49 (3328) 312 82-100
Fax: +49 (3328) 312 82-999
OD-OS, headquartered in Teltow near Berlin, Germany, is the pioneer of Navigated Retinal Imaging and Laser Treatment. Its groundbreaking Navilas® technology, currently available with 532 nm and 577 nm wavelength and microsecond pulsing option, enables the doctor to improve overall treatment accuracy as well as speed, comfort and safety in laser treatment of retinal disease. An optimized therapy concept aims at adding a durable effect and cost-effectiveness to pharmacological therapies.
Website address: www.oculussurgical.de
OCULUS, the inventor of the SDI®/BIOM® system - the first non-contact wide angle viewing system for vitreoretinal surgery - set up a special department "OCULUS Surgical." to improve care of its exclusive circle of customers – retina surgeons.
Ongoing improvement of existing products, trainings and distribution constitute the main tasks of this team of specialists.
The product range of the successful SDI®/BIOM® system is constantly expanding: in 2013 the new BIOM® ready was introduced, the world's first disposable wide angle viewing system. Disposable OCULUS-quality lenses, so-called BIOM® Optic Sets, round out the assortment of disposable products.